Tom is a senior analyst for the Broad’s Center for Mendelian Genomics, where he has a special focus on the role of regulatory genetic variation in inherited disease. He is also the clinical laboratory director for the Broad Institute’s Clinical Research Sequencing Platform. […]
David recently completed his undergraduate degree in Immunobiology at Brown University. He is developing cell lines to study human genetic variation as a research associate in the wet lab. […]
[…]
Grace Tiao is the Associate Director for Computational Genomics in the Translational Genomics Group and leads a team of computational biologists developing efficient methods and pipelines to produce and analyze large-scale sequencing callsets, including the Genome Aggregation Database (gnomAD), the UK BioBank, and rare disease cohorts generated by the Broad’s Center for Mendelian Genomics. She […]
Elise was a computational biologist who worked in the lab on the genomic diagnosis of rare disease families. Prior to joining the lab she worked at the NIH’s Undiagnosed Diseases Program. She is now a graduate student at Harvard. @valkanase […]
Ben is a Computational Scientist II in the Rehm lab working on developing methods for interpreting DNA sequencing data in the context of severe Mendelian diseases. He is the lead developer for our seqr rare disease analysis platform. @benweisburd […]
Zach is a postdoctoral fellow interested in developing novel methods to measure variant penetrance and understanding the underlying factors that affect variant pathogenicity. @zaczap […]
Alicia is a graduate student from the University of South Australia. She is working on the molecular diagnosis of rare genetic disease, with particular focus on disorders contributing to perinatal mortality. […]
Laurent is now a Sr. Research Scientist in the Computational Genomics at Vertex in San Diego. […]
Laura is a computational biologist jointly based in the MacArthur lab and the Broad Institute Data Sciences and Data Engineering (DSDE) platform. She works on the development of variant-calling pipelines for rare disease samples. […]
